vs
TRANSACT TECHNOLOGIES INC(TACT)与Verastem, Inc.(VSTM)财务数据对比。点击上方公司名可切换其他公司
TRANSACT TECHNOLOGIES INC的季度营收约是Verastem, Inc.的1.0倍($11.5M vs $11.2M)
该公司相关归属主体罗珀技术公司是一家控股集团,主要投资控股科技领域的各类企业,业务覆盖多个科技细分赛道,依托旗下子公司开展多元化科技业务布局。
Verastem, Inc.以Verastem Oncology品牌开展业务,是一家总部位于美国马萨诸塞州波士顿的制药企业,专注于开发抗癌治疗药物,该公司成立于波士顿,同时是纳斯达克生物技术指数成分股之一。
TACT vs VSTM — 直观对比
营收规模更大
TACT
是对方的1.0倍
$11.2M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $11.5M | $11.2M |
| 净利润 | — | $-98.5M |
| 毛利率 | 47.6% | — |
| 营业利润率 | -10.1% | -362.2% |
| 净利率 | — | -876.3% |
| 营收同比 | 11.9% | — |
| 净利润同比 | — | -311.1% |
| 每股收益(稀释后) | $-0.11 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
TACT
VSTM
| Q4 25 | $11.5M | — | ||
| Q3 25 | $13.2M | $11.2M | ||
| Q2 25 | $13.8M | $2.1M | ||
| Q1 25 | $13.1M | — | ||
| Q4 24 | $10.2M | — | ||
| Q3 24 | $10.9M | $0 | ||
| Q2 24 | $11.6M | $10.0M | ||
| Q1 24 | $10.7M | — |
净利润
TACT
VSTM
| Q4 25 | — | — | ||
| Q3 25 | $15.0K | $-98.5M | ||
| Q2 25 | $-143.0K | $-25.9M | ||
| Q1 25 | $19.0K | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-551.0K | $-24.0M | ||
| Q2 24 | $-319.0K | $-8.3M | ||
| Q1 24 | $-1.0M | — |
毛利率
TACT
VSTM
| Q4 25 | 47.6% | — | ||
| Q3 25 | 49.8% | — | ||
| Q2 25 | 48.2% | — | ||
| Q1 25 | 48.7% | — | ||
| Q4 24 | 44.2% | — | ||
| Q3 24 | 48.1% | — | ||
| Q2 24 | 52.7% | — | ||
| Q1 24 | 52.6% | — |
营业利润率
TACT
VSTM
| Q4 25 | -10.1% | — | ||
| Q3 25 | 0.1% | -362.2% | ||
| Q2 25 | -1.9% | -2047.9% | ||
| Q1 25 | -0.1% | — | ||
| Q4 24 | -10.3% | — | ||
| Q3 24 | -7.7% | — | ||
| Q2 24 | -3.8% | -182.8% | ||
| Q1 24 | -12.2% | — |
净利率
TACT
VSTM
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | -876.3% | ||
| Q2 25 | -1.0% | -1213.6% | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -5.1% | — | ||
| Q2 24 | -2.8% | -82.6% | ||
| Q1 24 | -9.7% | — |
每股收益(稀释后)
TACT
VSTM
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $0.00 | $-1.35 | ||
| Q2 25 | $-0.01 | $-0.62 | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $-0.80 | — | ||
| Q3 24 | $-0.06 | $-0.60 | ||
| Q2 24 | $-0.03 | $-0.31 | ||
| Q1 24 | $-0.10 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $20.4M | $137.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $31.1M | $-15.5M |
| 总资产 | $44.8M | $176.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
TACT
VSTM
| Q4 25 | $20.4M | — | ||
| Q3 25 | $20.0M | $137.7M | ||
| Q2 25 | $17.7M | $164.3M | ||
| Q1 25 | $14.2M | — | ||
| Q4 24 | $14.4M | — | ||
| Q3 24 | $11.3M | $113.2M | ||
| Q2 24 | $11.1M | $83.4M | ||
| Q1 24 | $10.6M | — |
总债务
TACT
VSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $40.5M | ||
| Q2 24 | — | $40.3M | ||
| Q1 24 | — | — |
股东权益
TACT
VSTM
| Q4 25 | $31.1M | — | ||
| Q3 25 | $31.8M | $-15.5M | ||
| Q2 25 | $31.3M | $36.1M | ||
| Q1 25 | $30.9M | — | ||
| Q4 24 | $30.6M | — | ||
| Q3 24 | $38.4M | $11.1M | ||
| Q2 24 | $38.5M | $18.9M | ||
| Q1 24 | $38.6M | — |
总资产
TACT
VSTM
| Q4 25 | $44.8M | — | ||
| Q3 25 | $45.0M | $176.9M | ||
| Q2 25 | $44.5M | $196.3M | ||
| Q1 25 | $44.2M | — | ||
| Q4 24 | $44.0M | — | ||
| Q3 24 | $50.5M | $126.4M | ||
| Q2 24 | $50.4M | $105.7M | ||
| Q1 24 | $51.9M | — |
负债/权益比
TACT
VSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.66× | ||
| Q2 24 | — | 2.14× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $609.0K | $-36.2M |
| 自由现金流经营现金流 - 资本支出 | $589.0K | — |
| 自由现金流率自由现金流/营收 | 5.1% | — |
| 资本支出强度资本支出/营收 | 0.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $7.6M | — |
8季度趋势,按日历期对齐
经营现金流
TACT
VSTM
| Q4 25 | $609.0K | — | ||
| Q3 25 | $3.6M | $-36.2M | ||
| Q2 25 | $3.6M | $-32.7M | ||
| Q1 25 | $-161.0K | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $327.0K | $-23.8M | ||
| Q2 24 | $636.0K | $-27.6M | ||
| Q1 24 | $-1.5M | — |
自由现金流
TACT
VSTM
| Q4 25 | $589.0K | — | ||
| Q3 25 | $3.6M | — | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $-171.0K | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $259.0K | — | ||
| Q2 24 | $499.0K | $-27.6M | ||
| Q1 24 | $-1.6M | — |
自由现金流率
TACT
VSTM
| Q4 25 | 5.1% | — | ||
| Q3 25 | 27.1% | — | ||
| Q2 25 | 25.9% | — | ||
| Q1 25 | -1.3% | — | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | 2.4% | — | ||
| Q2 24 | 4.3% | -275.8% | ||
| Q1 24 | -14.9% | — |
资本支出强度
TACT
VSTM
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.5% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.6% | — | ||
| Q2 24 | 1.2% | 0.1% | ||
| Q1 24 | 1.0% | — |
现金转化率
TACT
VSTM
| Q4 25 | — | — | ||
| Q3 25 | 242.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -8.47× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图